RecruitingPhase 2NCT06596434

4-Aminopyridine to Treat Skin Burns

Sponsor

John Elfar

Enrollment

200 participants

Start Date

Jan 1, 2026

Study Type

INTERVENTIONAL

Conditions

Wounds and Injuries Burns Second Degree Burn

Summary

Many patients suffer from traumatic burns and current treatments do not increase the regenerative potential of either skin grafts or the remaining uninjured skin. There is a need to develop treatments to accelerate and improve healing of burn injuries. More research is needed to evaluate the role of 4-AP, a promising new agent with an excellent safety profile, on wound and burn healing. The investigational treatment will be used to test the hypothesis that 4-AP accelerates burn healing in traumatically burned patients.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Drug: 4-Aminopyridine and Placebo for people with burns, second degree burn, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.